IL53520A - Derivatives of 5-(3,4-dihydroxy phenyl)2-oxazolidinones (and 2-thiazolidinones)and thiones and a process for their production - Google Patents

Derivatives of 5-(3,4-dihydroxy phenyl)2-oxazolidinones (and 2-thiazolidinones)and thiones and a process for their production

Info

Publication number
IL53520A
IL53520A IL53520A IL5352077A IL53520A IL 53520 A IL53520 A IL 53520A IL 53520 A IL53520 A IL 53520A IL 5352077 A IL5352077 A IL 5352077A IL 53520 A IL53520 A IL 53520A
Authority
IL
Israel
Prior art keywords
thiazolidinones
thiones
oxazolidinones
derivatives
production
Prior art date
Application number
IL53520A
Other languages
English (en)
Other versions
IL53520A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762655369 external-priority patent/DE2655369A1/de
Priority claimed from DE19772745320 external-priority patent/DE2745320A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL53520A0 publication Critical patent/IL53520A0/xx
Publication of IL53520A publication Critical patent/IL53520A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16—Sulfur atoms
IL53520A 1976-12-03 1977-12-02 Derivatives of 5-(3,4-dihydroxy phenyl)2-oxazolidinones (and 2-thiazolidinones)and thiones and a process for their production IL53520A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762655369 DE2655369A1 (de) 1976-12-03 1976-12-03 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung
DE19772745320 DE2745320A1 (de) 1977-10-05 1977-10-05 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung ii

Publications (2)

Publication Number Publication Date
IL53520A0 IL53520A0 (en) 1978-03-10
IL53520A true IL53520A (en) 1981-07-31

Family

ID=25771221

Family Applications (1)

Application Number Title Priority Date Filing Date
IL53520A IL53520A (en) 1976-12-03 1977-12-02 Derivatives of 5-(3,4-dihydroxy phenyl)2-oxazolidinones (and 2-thiazolidinones)and thiones and a process for their production

Country Status (19)

Country Link
JP (1) JPS5382777A (xx)
AT (1) AT357529B (xx)
AU (1) AU519994B2 (xx)
CA (1) CA1097657A (xx)
CH (1) CH635578A5 (xx)
CS (1) CS199694B2 (xx)
DD (1) DD133667A5 (xx)
DK (1) DK149850C (xx)
FR (1) FR2372814A1 (xx)
GB (1) GB1588639A (xx)
GR (1) GR64964B (xx)
HU (1) HU175676B (xx)
IE (1) IE46435B1 (xx)
IL (1) IL53520A (xx)
IT (1) IT1089341B (xx)
LU (1) LU78616A1 (xx)
NL (1) NL7713153A (xx)
SE (1) SE441446B (xx)
SU (1) SU888821A3 (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2701215C2 (de) * 1977-01-13 1982-10-14 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Thiazolin-2-thionen
US4348393A (en) * 1978-06-09 1982-09-07 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
DE3438839A1 (de) * 1984-10-19 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische praeparate
HU215433B (hu) * 1986-04-29 2000-05-28 Pfizer Inc. Eljárás új 2-oxo-5-fenil-pirimidin-származékok előállítására
US5459145A (en) * 1988-01-19 1995-10-17 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
JPH01135098U (xx) * 1988-03-11 1989-09-14
WO1991007177A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
US5461056A (en) * 1992-05-08 1995-10-24 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
GB9212673D0 (en) * 1992-06-15 1992-07-29 Celltech Ltd Chemical compounds
GB9222253D0 (en) * 1992-10-23 1992-12-09 Celltech Ltd Chemical compounds
GB9226830D0 (en) * 1992-12-23 1993-02-17 Celltech Ltd Chemical compounds
US5622977A (en) * 1992-12-23 1997-04-22 Celltech Therapeutics Limited Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
EP0738268B1 (en) * 1993-12-22 2004-03-03 Celltech R&D Limited Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process
US6245774B1 (en) 1994-06-21 2001-06-12 Celltech Therapeutics Limited Tri-substituted phenyl or pyridine derivatives
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
GB9412573D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412571D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412672D0 (en) * 1994-06-23 1994-08-10 Celltech Ltd Chemical compounds
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
GB9526245D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9526246D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
GB9622363D0 (en) * 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
GB9625184D0 (en) * 1996-12-04 1997-01-22 Celltech Therapeutics Ltd Chemical compounds
US6057329A (en) * 1996-12-23 2000-05-02 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives
GB9705361D0 (en) 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
GB9924862D0 (en) 1999-10-20 1999-12-22 Celltech Therapeutics Ltd Chemical compounds

Also Published As

Publication number Publication date
LU78616A1 (xx) 1978-04-20
IT1089341B (it) 1985-06-18
AU3117577A (en) 1979-06-07
DK149850B (da) 1986-10-13
HU175676B (hu) 1980-09-28
NL7713153A (nl) 1978-06-06
FR2372814B1 (xx) 1980-10-10
SE7713635L (sv) 1978-06-04
GB1588639A (en) 1981-04-29
ATA868677A (de) 1979-12-15
SE441446B (sv) 1985-10-07
IE772446L (en) 1978-06-03
IL53520A0 (en) 1978-03-10
GR64964B (en) 1980-06-10
SU888821A3 (ru) 1981-12-07
IE46435B1 (en) 1983-06-15
JPS5382777A (en) 1978-07-21
DK149850C (da) 1987-04-27
CH635578A5 (en) 1983-04-15
CA1097657A (en) 1981-03-17
DD133667A5 (de) 1979-01-17
CS199694B2 (en) 1980-07-31
DK536677A (da) 1978-06-04
AT357529B (de) 1980-07-10
AU519994B2 (en) 1982-01-07
FR2372814A1 (fr) 1978-06-30
JPS6154792B2 (xx) 1986-11-25

Similar Documents

Publication Publication Date Title
IL53520A (en) Derivatives of 5-(3,4-dihydroxy phenyl)2-oxazolidinones (and 2-thiazolidinones)and thiones and a process for their production
PL202177A1 (pl) Sposob wytwarzania nowych pochodnych 1-fenylo-2,3,4,5-czterowodoro-1h-3-benzazepiny
ES508490A0 (es) "un metodo de produccion de derivados de tiazolidina".
HU172527B (hu) Sposob poluchenija novykh proizvodnykh 1,2-ditiola
PL197201A1 (pl) Srodek chwastobojczy i sposob wytwarzania nowych pochodnych 1,3,4-tiadiazolilowych
ZA764847B (en) 1,2-benzisoxazole derivatives and production thereof
EG12752A (en) Process for preparing of 3,5,5 trimethylhexanoyl freeocene
YU165077A (en) Process for preparing 2,5-bis(benzoxazolyl)-thiophene compounds
SU725557A3 (en) Method of preparing 1,2,3-thiadiazol-5-yl-ureas
BG36499A3 (en) Method for preparing derivatives of 2, 5- dihydro- 1, 2- thiazino- (5 b)- indol- 3- carboxamide- 1, 1- dioxide
BG25075A3 (en) A method of obtaining 1,2,4-triazol derivatives
RO76374A (ro) Procedeu de preparare a unor spiro-derivati de 3-(3,5-dihalofenil)-oxazolidin-2,4-diona
GB2036006B (en) Substituted 2-amino or 2-thio derivatives of 4,5-diphenyl oxazoles and their production
PL205382A1 (pl) Sposob wytwarzania pochodnych 2h-1,2,4-triazynonu
IL52194A (en) Production of 0,0-dialkyl-phosphorochloridothionates
IL52643A0 (en) Method of preparing 2,3-dichloroanisole
SE438506B (sv) Forfarande for framstellning av 5,6-dehydropenicilliner
HU171558B (hu) Sposob poluchenija proizvodnykh 1,2,4-oksadiazola i ikh solej
PL203486A1 (pl) Sposob wytwarzania nowych pochodnych 6,7-dwumetoksy-1,2,3,4-czterowodoro-1-izochinolino-acetamidu
BG50387A3 (en) A process of preparing heterocyclic derivatives of /4-phenylpiperazine-1-il-aryloxymethyl-1,3- dioxolan-2-il/-methyl-1h-imidazoles and 1h-1,2,4-
ZA776128B (en) Novel prostaglandin-like cyclobutane derivatives and process for their manufacture
AU505137B2 (en) 5-(cyano-2-pyridyloxymethyl) oxazolidine derivatives
CS191176B2 (en) Method of preparing substituted 1-phenyl-2,2,2-trihalogene ethanolesters
PL197185A1 (pl) Srodek chwastobojczy oraz sposob wytwarzania/5-(2-chloro-1,1-dwumetyloetylo)-1,3,4-tiadiazolilo-)2/-mocznikow
SE402773B (sv) Forfarande for framstellning av 1,2,4-bensotiadiazin-1,1-dioxid-derivat